Motiva Implants, Explained: What the Technology Actually Is

Motiva comes up so often in breast augmentation consultations that it can start to sound like a decision in itself, the way a car or skincare brand name does. It isn't. Motiva is one implant manufacturer among several a surgeon might use, and understanding what actually distinguishes it can help you ask sharper questions, whichever implant you and your surgeon land on.

What Motiva actually is

Motiva implants are FDA-cleared, CE-marked silicone gel-filled breast implants manufactured by Establishment Labs, a company based in Costa Rica. Every current Motiva implant, across its SmoothSilk, Ergonomix, and Ergonomix2 lines, uses the same SmoothSilk/SilkSurface shell: a smooth, nanotextured surface with an average roughness of around 4 microns. That classification, smooth/nanotextured rather than macrotextured, is part of what Establishment Labs points to on biocompatibility, and it's worth asking your own surgeon to walk through in the context of your case rather than taking as a given.

Three product lines, not one implant

SmoothSilk is available in round or anatomical shapes and is the line most commonly used in primary augmentation. Ergonomix is a round implant designed to behave dynamically: sitting round when a patient is lying down and taking on more of a teardrop shape when upright, intended to follow the chest wall's natural slope. Ergonomix2 is the newer generation, built on the same shell but with added softness and pliability; a small 2024 comparative study (31 Ergonomix2 patients versus 51 Ergonomix1 controls) found improvements in contour symmetry and a more natural feel on elastographic analysis, along with a shorter learning curve for surgeons. None of that makes one line automatically the right choice for you. It depends on your tissue, your goals, and your surgeon's own experience with each design.

What the published evidence actually shows

Motiva's implants have gone through FDA pivotal IDE trials, with 3- and 5-year data published between 2024 and 2026. In the 5-year data, reoperation rates were 8.8% for primary augmentation and 36% for revisional augmentation, the higher revisional figure reflecting the added complexity of repeat surgery rather than something specific to the brand. Notably, the leading reasons for reoperation in primary cases had shifted toward subjective factors like size or position rather than implant failure such as rupture or capsular contracture. Separate retrospective cohort studies, including a 5,813-case single-center series and an 801-patient comparative cohort, have reported capsular contracture rates for Motiva's nanotextured shell that were lower than several other implant brands in those specific studies. That's useful context, not a prediction for any individual patient: these are retrospective, brand-specific series, and the FDA's own pivotal data still lists capsular contracture among the reasons patients return for revisional surgery.

The brand is one input, not the whole decision

Chest width, tissue thickness, and skin elasticity are what actually determine which implant profile and size will look proportionate on you; the brand is downstream of that. A surgeon who can explain why a specific Motiva product, or a different manufacturer's implant, fits your measurements is doing the job properly. One who leads with a brand name before examining you is doing something else. It's a reasonable enough thing to ask about directly at a consultation.

Recovery, and what happens afterward

Regardless of implant brand, the recovery arc for breast augmentation looks similar: swelling and bruising peak in the first week, most people return to desk work within one to two weeks, and a final result typically settles over three to six months as swelling fully resolves. Implants, including Motiva's, are not considered lifetime devices. The FDA recommends surveillance imaging, MRI or ultrasound, starting around five to six years after surgery and then every two to three years, so that any changes are caught early rather than by symptoms alone.

Worth asking before your consultation

A few questions travel well into any consultation involving Motiva: which of the three product lines is being suggested and why, what the surgeon's own experience with that specific implant looks like, whether the implant's serial number will be logged in a national registry where one exists, and what the practice's long-term follow-up and surveillance-imaging schedule actually involves. None of those questions require you to have already decided on surgery. They're just as useful while you're still weighing whether to.